Latest news articles

Added 9 days ago Drug news

MediciNova announces phase III clinical trial plan for MN 166 (ibudilast) in progressive MS

MediciNova, Inc.,announced its plans for a Phase III clinical trial of MN 166 (ibudilast) in progressive multiple sclerosis (progressive MS)...

Added 1 month ago Drug news

FDA and EMA accept for review ozanimod for the treatment relapsing-remitting multiple sclerosis

Celgene/BMS announced that the FDA has accepted for review the New Drug Application for ozanimod for the treatment of people...

Added 2 months ago Drug news

Mayzent's data shows a positive impact on cognitive processing speed in people living with secondary progressive MS

Novartis announced a new analysis of the Phase III EXPAND study demonstrating that treatment with Mayzent (siponimod) had a clinically...

Search all news articles for Multiple sclerosis

Learning Zones

An Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.

Migraine Knowledge Centre

Migraine Knowledge Centre

The Migraine Knowledge Centre features latest research on the prevalence and impact of migraine, the proposed neurological basis of the condition (and how this is being translated into new and exciting drug therapies), as well as current patient care strategies collated from headache organisations worldwide.

Inflammatory bowel disease assessment tools

Inflammatory bowel disease assessment tools

'New IBD assessment tools at a glance' - an educational symposium sponsored by Sandoz.

Load more


Association of British Neurologists: revised (2015) guidelines for prescribing disease-modifying treatments in multiple sclerosis

This 2015 revised guideline replaces former versions. It includes all newly approved or licensed treatments for MS and represents a consensus concerning their use.

Added 4 years ago

Multiple sclerosis in adults: management

This guideline covers diagnosing and managing multiple sclerosis in people aged 18 and over.

Added 4 years ago

Urinary incontinence in neurological disease: assessment and management

This guideline covers assessing and managing urinary incontinence in children, young people and adults with neurological disease.

Added 6 years ago

Search all guidelines for Multiple sclerosis

Journal articles

The hippocampus in multiple sclerosis.

Some of the clinical manifestations of multiple sclerosis, such as memory impairment and depression, are, at least partly, related to involvement of the hippocampus. Pathological studies have shown extensive demyelination...

Added 1 month ago

Multiple sclerosis: effect of beta interferon treatment on survival.

Worldwide, the beta interferons remain the most commonly prescribed disease-modifying drugs for multiple sclerosis. However, it is unclear if they alter survival. We investigated the association between beta interferon and mortality...

Added 1 month ago

How people with multiple sclerosis experience the influence of nutrition and lifestyle factors on the disease.

Purpose: Increasing knowledge suggests that nutrition and lifestyle factors affect multiple sclerosis. This study explores how people with multiple sclerosis experience daily multiple sclerosis disease activity and the influence...

Added 1 month ago

Search all journal articles for Multiple sclerosis

Clinical trials

A Study to Evaluate the Safety, Tolerability, and Efficacy of BIIB017 (Peginterferon Beta-1a) in Pediatric Participants for the Treatment of Relapsing-Remitting Multiple Sclerosis

This study will evaluate the safety, tolerability, and descriptive efficacy of BIIB017 in pediatric participants with relapsing-remitting multiple sclerosis (RRMS) and to assess the pharmacokinetics (PK) of BIIB017 in pediatric participants...

Added 1 month ago

Dose-finding Study for SAR442168 in Relapsing Multiple Sclerosis

To determine the efficacy of SAR442168 in reducing the number of new brain lesions reported in Magnetic Resonance Imaging (MRI)

Added 1 month ago

Study to Evaluate the Efficacy and Safety of Dimethyl Fumarate (Tecfidera) and Peginterferon Beta-1a (Plegridy) for the Treatment of Relapsing-Remitting Multiple Sclerosis in Pediatric Participants

The main objective of the study is to evaluate the efficacy of dimethyl fumarate (Tecfidera) and peginterferon beta-1a (Plegridy), both compared with placebo, in pediatric participants with RRMS.

Added 1 month ago

Search all clinical trials for Multiple sclerosis


Multiple sclerosis: clinical review

Accrediting body
MIMS Learning - Monthly Index of Medical Specialities
Credits available
Registration required
Subscription fee
Search all CME for Multiple sclerosis